GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Avvaa World Health Care Products AVVH · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

+13.79%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$157,859

FY2022FY2026

Net income

−$18,511

FY2022FY2026

Free cash flow

$32,730

FY2022FY2026

Shareholders' equity

$120,377

FY2022FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Revenue$157,859$4,650—$2,000—
Gross profit$52,481$1,521—−$7,763—
Operating income$4,767−$34,724−$42,751−$75,257−$28,974
Net income−$18,511−$39,123−$42,751−$75,257−$28,974
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Total assets$1.6m$243,193——$273,053
Cash and short-term investments$24,074$11,818——$126,603
Total liabilities$1.5m$284,266——$90,577
Debt$1.5m$250,000———
Shareholders' equity$120,377−$41,073——$182,476
Shares outstanding967m966m966m966m966m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Cash from operations$32,734−$246,008———
Capital spending−$4————
Free cash flow$32,730−$246,008———

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Revenue$47,292$64,767$25,901$39,477$27,713$4,650——
Gross profit$20,337−$5,072$13,388$16,452—$1,521——
Operating income$2,611−$8,784−$11,784$6,673$18,663−$5,599−$726−$25,201
Net income−$6,433$6,974−$22,969−$8,190$5,674−$7,321−$2,894−$25,711
Diluted earnings per share-0.000.00-0.00-0.000.00-0.00-0.00-0.00
Cash from operations——$1.0m—————
Total assets$1.5m$1.6m$1.4m$1.3m$849,362$243,193$251,376—
Cash and short-term investments$96,996$24,074$192,742$14,255$1,284$11,818$1,375—
Shareholders' equity$113,944$120,377$114,921$156,411−$35,399−$41,073−$28,786—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue329.0%37.0%11.9%
Operating income—-27.9%—
Net income-37.3%—-47.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.2%———
Operating margin-18.4%———
Net margin-35.5%———

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Price to earnings-164.5-42.5-11.2-6.4-28.0
Price to sales19.3357.2—239.9—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return192%30%-60%-79%2435%29096%139536%51100%51100%300%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 5 Jun 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.